Elisabeth Bjork - Net Worth and Insider Trading

Elisabeth Bjork Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elisabeth Bjork owns 1 companies in total, including Rocket Pharmaceuticals Inc (RCKT) .

Click here to see the complete history of Elisabeth Bjork’s form 4 insider trades.

Insider Ownership Summary of Elisabeth Bjork

Ticker	Comapny	Transaction Date	Type of Owner
RCKT	Rocket Pharmaceuticals Inc	2020-04-20	director

Elisabeth Bjork Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elisabeth Bjork Ownership Network

Ownership Network List of Elisabeth Bjork

No Data

Ownership Network Relation of Elisabeth Bjork

Elisabeth Bjork Owned Company Details

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Elisabeth Bjork is the director of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include General Counsel Martin Wilson , director & See Remarks Gaurav Shah , and See Remarks John Militello .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Elisabeth Bjork made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 24,361 shares made by John Militello , a net sale of 51,145 shares made by Gaurav Shah , and a net sale of 308,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 385,818 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 385,818 shares. During the past 18 months, 502,020 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 502,020 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

Elisabeth Bjork Mailing Address

Above is the net worth, insider trading, and ownership report for Elisabeth Bjork. You might contact Elisabeth Bjork via mailing address: C/o Rocket Pharmaceuticals, Inc., 350 Fifth Avenue, Suite 7530, New York Ny 10116.

Discussions on Elisabeth Bjork

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.